Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
News
Sports
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
Podjoint Logo
US
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/43/bc/67/43bc6734-2f26-36da-f4fa-c935cf749ee0/mza_4535681404373065078.jpg/600x600bb.jpg
The Readout Loud
STAT
380 episodes
5 days ago
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
Show more...
Business
RSS
All content for The Readout Loud is the property of STAT and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
Show more...
Business
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/43/bc/67/43bc6734-2f26-36da-f4fa-c935cf749ee0/mza_4535681404373065078.jpg/600x600bb.jpg
376: BridgeBio’s great week and Moderna’s unraveling
The Readout Loud
38 minutes
5 days ago
376: BridgeBio’s great week and Moderna’s unraveling
Has BridgeBio’s business model worked? How are executives at Moderna dealing with the company’s slump? And who will the hosts dress up as for Halloween? We discuss all that on this week’s episode of the “The Readout LOUD,” STAT’s biotech podcast. We bring on BridgeBio CEO Neil Kumar to discuss the company’s positive Phase 3 readouts and our colleague Jason Mast to discuss Moderna’s struggles following its Covid-19 vaccine boom.
The Readout Loud
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.